| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price |
|---|---|---|---|---|---|---|---|---|
| IFN-alpha 1 | HOT IFA-M52H3 | Mouse IFN-alpha 1 Protein, His Tag |  Mouse | HEK293 |  | SDS-PAGE | $395.00 100ug | |
| IFN-alpha 1 | Human IFN-alpha 1 Protein, Fc Tag (MALS & BLI verified) |  Human | HEK293 |  | MALSSDS-PAGE | $395.00 100ug | ||
| IFN-alpha 1 | Human IFN-alpha 1 Protein, His Tag | Human | HEK293 |  | SDS-PAGE | $395.00 100ug | ||
| IFN-alpha 1 | Avitag IFA-H82E4 | Biotinylated Human IFN-alpha 1 Protein, His,Avitag™ (HPLC & SPR verified) | Human | HEK293 |  | HPLCSDS-PAGE | $360.00 25ug |
| English Name | Research Code | Highest Development Stage | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Interferon beta (Toray/Daiichi Sankyo) | DL-8234 | Approved | Toray Industries Inc | Feron | Japan | Medulloblastoma; Melanoma; Hepatitis C; Astrocytoma; Glioblastoma; Hepatitis B | null | 1985-04-01 | Medulloblastoma; Glioblastoma; Hepatitis B; Hepatitis C; Astrocytoma; Melanoma | Details |
| Recombinant human interferon alfa-2b (Harbin Pharmaceutical Group Bioengineering) | Approved | Harbin Pharmaceutical Group Holding Co Ltd | 里亚美, 利分能 | Mainland China | Hepatitis, Viral, Human; Leukemia, Hairy Cell; Leukemia, Myelogenous, Chronic; Lymphoma, Non-Hodgkin; Multiple Myeloma; Condylomata Acuminata; Varicella Zoster Virus Infection | Harbin Pharmaceutical Group Pharmaceutical Co Ltd | 1996-01-01 | Leukemia, Myelogenous, Chronic; Leukemia, Hairy Cell; Varicella Zoster Virus Infection; Multiple Myeloma; Hepatitis, Viral, Human; Lymphoma, Non-Hodgkin; Condylomata Acuminata | Details | |
| Recombinant human interferon α2b biosimilar (Harbin High-Tech White Swan Pharmaceutical) | Approved | Harbin High-Tech Group Baitian'Er Pharmaceutical Co Ltd | Fu Li Sheng | Leukemia, Hairy Cell; Hepatitis; Multiple Myeloma; Leukemia, Myeloid, Chronic-Phase; Lymphoma, Non-Hodgkin; Herpes Zoster; Condylomata Acuminata | Details | |||||
| Anifrolumab | MDX-1333; MEDI-546 | Approved | Medimmune Llc, Medarex Inc | SAPHNELO | United States | Lupus Erythematosus, Systemic | Astrazeneca Ab | 2021-07-30 | Polymyositis; Hidradenitis; Dermatomyositis; Myositis; Atherosclerosis; Scleroderma, Systemic; Lupus Erythematosus, Cutaneous; Sjogren's Syndrome; Autoimmune Diseases; Lupus Nephritis; Lupus Erythematosus, Systemic; Cardiovascular Diseases; Hidradenitis Suppurativa; Vitiligo | Details |
| Recombinant human interferon α2b biosimilar (Zhejiang Hansheng) | Approved | Zhejiang Hansheng Pharmaceutical Co Ltd Of Beisheng Pharma | 莱福隆 | Mainland China | Virus Diseases; Neoplasms | Zhejiang Hansheng Pharmaceutical Co Ltd Of Beisheng Pharma | 1999-01-01 | Virus Diseases; Neoplasms | Details |
